|
SERVICE DE NEUROLOGIE ET PATHOLOGIE DU MOUVEMENTHôpital de la Timone / Rue Saint-Pierre / 13385 Marseille Cedex 5
Téléphone : 04-91-38-43-33
Fax : 04-91-38-43-36
Courriel : jean-philippe.azulay@ap-hm.fr
Equipes Acueil des Masters Contrats Liste des Personnels Publications des 2 dernières années Thèses
| Effectifs |
Enseignants - Chercheurs et Ingénieurs Universitaires : 3
Médecins hospitaliers : 2
Chercheurs et Ingénieurs (INSERM, CNRS, autres) :
Personnel Administratif et Technique Universitaire :
Personnel Administratif et Technique (INSERM, CNRS, autres) :
Internes :
Etudiants (3ème cycle,Post-Doc, Boursiers...) :
| Equipes de recherche |
- Maladie de Parkinson - (Responsable : Jean-Philippe AZULAY)
- Maladies de Gilles de la Tourette - (Responsable : Jean-Philippe AZULAY)
- Chorée de Huntington - (Responsable : Jean-Philippe AZULAY)
- Posture - (Responsable : Jean-Philippe AZULAY)
- Locomotion - (Responsable : Jean-Philippe AZULAY)
- Electrophysiologie des noyaux gris centraux - (Responsable : Jean-Philippe AZULAY)
- Motivation - (Responsable : Jean-Philippe AZULAY)
- Addictions et ganglions de la base - (Responsable : Jean-Philippe AZULAY)
| - | Approche transversale du rôle du noyau subthalamique dans la motivation et la dépendance aux drogues : du rat au patient parkinsonien - J.P. AZULAY - 2009 - ANR |
| Contrats AP-HM | |
| - | Physiopathologie des oscillations neuronales au sein des réseaux subthalamo-corticaux dans la maladie de Parkinson - J.P. AZULAY - 2009 - AORC |
| PHRC | |
| - | Etude sur les fluctuations - J.P. AZULAY - 2010 - PHRC |
| AZULAY Jean-Philippe - PU-PH | 04-91-38-43-33 |
| EUSEBIO Alexandre - CCA | 04-91-38-43-33 |
| FLUCHERE Fréderique - CCA | 04-91-38-43-33 |
| MUNDLER Laura - ARC | 04-91-38-43-33 |
| WITJAS Tatiana - PH | 04-91-38-43-33 |
| Publications des 2 dernières années |
| - | Azulay JP. Movement disorders. Rev Prat. 2009 May 20;59(5):723-7. |
| - | Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN; NNIPPS Study Group. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain. 2009;132(Pt 1):156-71. |
| - | Dehorter N, Guigoni C, Lopez C, Hirsch J, Eusebio A, Ben-Ari Y, Hammond C. Dopamine-deprived striatal GABAergic interneurons burst and generate repetitive gigantic IPSCs in medium spiny neurons. J Neurosci. 2009;29(24):7776-87. |
| - | Delaveau P, Salgado-Pineda P, Witjas T, Micallef-Roll J, Fakra E, Azulay JP, Blin O. Dopaminergic modulation of amygdala activity during emotion recognition in patients with Parkinson disease. J Clin Psychopharmacol. 2009;29(6):548-54. |
| - | Devos D; French DUODOPA Study Group. Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease. Mov Disord. 2009;24(7):993-1000. |
| - | Dhaenens CM, Burnouf S, Simonin C, Van Brussel E, Duhamel A, Defebvre L, Duru C, Vuillaume I, Cazeneuve C, Charles P, Maison P, Debruxelles S, Verny C, Gervais H, Azulay JP, Tranchant C, Bachoud-Levi AC, Dürr A, Buée L, Krystkowiak P, Sablonnière B, Blum D; Huntington French Speaking Network. A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease. Neurobiol Dis. 2009;35(3):474-6. |
| - | Eusebio A, Pogosyan A, Wang S, Averbeck B, Gaynor LD, Cantiniaux S, Witjas T, Limousin P, Azulay JP, Brown P. Resonance in subthalamo-cortical circuits in Parkinson's disease. Brain. 2009;132:2139-50. |
| - | Eusebio A, Brown P. Synchronisation in the beta frequency-band--the bad boy of parkinsonism or an innocent bystander? Exp Neurol. 2009;217(1):1-3. |
| - | Goizet C, Boukhris A, Durr A, Beetz C, Truchetto J, Tesson C, Tsaousidou M, Forlani S, Guyant-Maréchal L, Fontaine B, Guimarães J, Isidor B, Chazouillères O, Wendum D, Grid D, Chevy F, Chinnery PF, Coutinho P, Azulay JP, Feki I, Mochel F, Wolf C, Mhiri C, Crosby A, Brice A, Stevanin G. CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5. Brain. 2009;132:1589-600. |
| - | Micallef J, Rey M, Eusebio A, Audebert C, Rouby F, Jouve E, Tardieu S, Blin O. Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects. Br J Clin Pharmacol. 2009;67(3):333-40 |
| - | Pogosyan A, Gaynor LD, Eusebio A, Brown P. Boosting cortical activity at Beta-band frequencies slows movement in humans. Curr Biol. 2009;19(19):1637-41. |
| - | Robert G, Drapier D, Verin M, Millet B, Azulay JP, Blin O. Cognitive impulsivity in Parkinson's disease patients: assessment and pathophysiology. Mov Disord. 2009;24(16):2316-27 |
| - | Saleh N, Moutereau S, Durr A, Krystkowiak P, Azulay JP, Tranchant C, Broussolle E, Morin F, Bachoud-Lévi AC, Maison P. Neuroendocrine disturbances in Huntington's disease. PLoS One. 2009;4(3):e4962. |
| - | Sauleau P, Eusebio A, Vandenberghe W, Nuttin B, Brown P. Deep brain stimulation modulates effects of motivation in Parkinson's disease. Neuroreport. 2009;20(6):622-6. |
| - | Sauleau P, Eusebio A, Thevathasan W, Yarrow K, Pogosyan A, Zrinzo L, Ashkan K, Aziz T, Vandenberghe W, Nuttin B, Brown P. Involvement of the subthalamic nucleusin engagement with behaviourally relevant stimuli. Eur J Neurosci. 2009;29(5):931-42. |
| - | Attarian S, Boucraut J, Hubert AM, Uzenot D, Delmont E, Verschueren A, Franques J, Azulay JP, Pouget J. Chronic ataxic neuropathies associated with anti-GD1b IgM antibodies: response to IVIg therapy. J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):61-4. |
| - | Azulay JP, Defebvre L. [Gait disorders - foreword]. Rev Neurol (Paris). 2010 ;166(2):141. |
| - | Azulay JP, Vacherot F, Vaugoyeau M. [Gait disorders: mechanisms and classification]. Rev Neurol (Paris). 2010;166(2):142-8. Rascol O, Azulay JP, Blin O, Bonnet AM, Brefel-Courbon C, Césaro P, Damier P, Debilly B, Durif F, Galitzky M, Grouin JM, Pennaforte S, Villafane G, Yaici S, Agid Y. Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study. Mov Disord. 2010;25(3):368-76. |
| - | Cantiniaux S, Vaugoyeau M, Robert D, Horrelou-Pitek C, Mancini J, Witjas T, Azulay JP. Comparative analysis of gait and speech in Parkinson's disease: hypokinetic or dysrhythmic disorders? J Neurol Neurosurg Psychiatry. 2010;81(2):177-84. |
| - | Delaveau P, Salgado-Pineda P, Fossati P, Witjas T, Azulay JP, Blin O. Dopaminergic modulation of the default mode network in Parkinson's disease. Eur Neuropsychopharmacol. 2010;20(11):784-92 |
| - | Dujardin K, Dubois B, Tison F, Durif F, Bourdeix I, Péré JJ, Duhamel A; Executive study group. Parkinson's disease dementia can be easily detected in routine clinical practice. Mov Disord. 2010;25(16):2769-76. |
| - | Franques J, Azulay JP, Pouget J, Attarian S. [Chronic inflammatory demyelinating polyradiculoneuropathy]. Rev Med Interne. 2010;31(6):411-6. |
| - | Litvak V, Eusebio A, Jha A, Oostenveld R, Barnes GR, Penny WD, Zrinzo L, Hariz MI, Limousin P, Friston KJ, Brown P. Optimized beamforming for simultaneous MEG and intracranial local field potential recordings in deep brain stimulation patients. Neuroimage. 2010;50(4):1578-88. |
| - | Moreau C, Cantiniaux S, Delval A, Defebvre L, Azulay JP. Gait disorders in Parkinson's disease: and pathophysiological approaches. Rev Neurol (Paris). 2010;166(2):158-67. |
| - | Payoux P, Brefel-Courbon C, Ory-Magne F, Regragui W, Thalamas C, Balduyck S, Durif F, Azulay JP, Tison F, Blin O, Esquerre JP, Rascol O. Motor activation in multiple system atrophy and Parkinson disease: a PET study. Neurology. 2010;75(13):1174-80. |
| - | Rascol O, Azulay JP, Blin O, Bonnet AM, Brefel-Courbon C, Césaro P, Damier P, Debilly B, Durif F, Galitzky M, Grouin JM, Pennaforte S, Villafane G, Yaici S, Agid Y. Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study. Mov Disord. 2010;25(3):368-76. |
| - | Saleh N, Moutereau S, Azulay JP, Verny C, Simonin C, Tranchant C, El Hawajri N, Bachoud-Lévi AC, Maison P; Huntington French Speaking Group. High insulinlike growth factor I is associated with cognitive decline in Huntington disease. Neurology. 2010;75(1):57-63. |
| - | Somma-Mauvais H, Soulayrol S, Duvocelle A, Azulay JP, Gastaut JL. [Treating writer's cramp: 14 years' experience with botulinum toxin]. Rev Neurol (Paris) 2010;166(6-7):630-8. |
| - | Vacherot F, Attarian S, Eusebio A, Azulay JP. Excitability of the lower-limb area of the motor cortex in Parkinson's disease. Neurophysiol Clin. 2010;40(4):201-8. |
| - | Vacherot F, Attarian S, Vaugoyeau M, Azulay JP. A motor cortex excitabilityand gait analysis on Parkinsonian patients. Mov Disord. 2010;25(16):2747-55 |
| - | Vaugoyeau M, Azulay JP. Role of sensory information in the control of postural orientation in Parkinson's disease. J Neurol Sci. 2010 Feb 15;289(1-2):66-8. |
© Faculté de Médecine de Marseill l Mentions légales l Mise à jour du 23 février 2012